‘Your Genome Isn’t Really Secret,’ Says Google Ventures’s Bill Maris
‘Your Genome Isn’t Really Secret,’ Says Google Ventures’s
Bill Maris
The venture capitalist wants to extend human life
expectancy, and he says fears over privacy and the security of DNA data
shouldn’t stand in the way.
By Eric Newcomer October 20, 2015 — 3:54 PM PDT
Bill Maris has a simple proposition for those who are a
little freaked out by his efforts to digitize human DNA: “If we each keep our
genetic information secret, then we’re all going to die.” OK then.
The Google Ventures managing partner has shifted the
firm’s focus this year to investing in companies that aim to slow aging,
reverse disease, and extend life. Many of those life-sciences companies do this
by collecting customers’ genetic information and looking for trends.
Hoarding this kind of personal data introduces risks, particularly
as hacking becomes an everyday occurrence. But Maris dismissed privacy concerns
surrounding the prospect of genomic data becoming public. “What are you worried
about?” he said at a Wall Street Journal technology conference in Laguna Beach,
Calif., on Tuesday. “Your genome isn’t really secret.”
That’s because people constantly leave traces of their
genomic material lying around in public. If someone really wanted the
information, they don’t need to hack a server. They could just pull a cup with
your saliva out of the trash and test it, said Maris, who studied neuroscience
and helped form Calico, a company within Google parent company Alphabet that
focuses on age-related diseases. Google Ventures is an investor in 23andMe,
which sells a $99 DNA spit kit to provide customers with ancestry information.
DNA technology has come a long way. Maris said the
technical problems around editing the genome are practically solved. As for his
line about how we’re all going to die: He didn’t mean immediately. Maris is a
fierce advocate for life extension, racing his own mortality to invest in
companies that might keep him and the rest of humanity alive longer—or,
perhaps, indefinitely.
In the interview, Maris spoke alongside Peter Diamandis,
the chief executive officer of the XPrize foundation, which organizes complex
technology competitions. They’re both preoccupied with doubling human life
expectancy. Analyzing a large database of genomic data is important to
achieving that goal.
If people started living drastically longer, we might
find ourselves with some new problems, such as how to feed everyone. Diamandis
said that as people get happier and healthier, they have fewer kids. If people
would eat less meat, Maris said there would be more room to grow food for them
all. Maris, who doesn’t eat meat and can’t stand the taste, touted one of his
investments, Impossible Foods, as a company that’s creating meat substitutes
capable of satisfying beef lovers. “It was so much like meat that it disgusted
me,” Maris said. “I couldn’t finish it.”
—With Caroline Chen
Comments
Post a Comment